Gordon, Jessica Martyanov, Viktor Magro, Cynthia Wildman, Horatio Wood, Tammara Huang, Wei-Ti Crow, Mary Whitfield, Michael Spiera, Robert Additional file 2: of Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial Dermatopathology results. αSMA alpha smooth muscle actin, Egr early growth response protein. (DOCX 15 kb) muscle actin;Additional;trial Dermatopathology results;growth response protein;Nilotinib;open-label;DOCX 15 kb;Egr;α SMA;Tasigna;sclerosis 2015-08-18
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_of_Nilotinib_Tasigna_in_the_treatment_of_early_diffuse_systemic_sclerosis_an_open-label_pilot_clinical_trial/4440452
10.6084/m9.figshare.c.3636080_D5.v1